Blood tests showed no measurable immune cell activation or antibody production in response to these cells. Before the ...

Modular Medical (Nasdaq:MODD) announced that it began converting its manufacturing line to produce next-generation insulin ...

Scientists treated a person’s type 1 diabetes with genetically modified insulin-producing cells that evaded immune system attacks. This is the first therapy for the condition that does not require imm ...

Modular Medical (Nasdaq:MODD) announced that it began converting its manufacturing line to produce next-generation insulin ...